Scandal in the clinic: Ex-technical director in court for infidelity!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Trial begins at the Oldenburg regional court: Former technical director of the Wilhelmshaven Clinic charged with breach of trust.

Prozessbeginn am Landgericht Oldenburg: Ehemaliger Technischer Leiter des Klinikums Wilhelmshaven wegen Untreue angeklagt.
Trial begins at the Oldenburg regional court: Former technical director of the Wilhelmshaven Clinic charged with breach of trust.

Scandal in the clinic: Ex-technical director in court for infidelity!

A trial begins today at the Oldenburg regional court that could cause major waves for the Wilhelmshaven Clinic. The 59-year-old technical director of the clinic is charged with serious breach of trust. Between 2015 and 2019 he is said to have awarded contracts to craft businesses in Wilhelmshaven and the Friesland district, in return he received valuable, free or discounted materials and services for his own house construction. The total of these unlawful advantages amounts to around 370,000 euros. In total, the man is accused of 40 crimes, and the financial damage to the clinic will be determined in detail during the trial.

The criminal allegations were sparked by a complaint from a craft business, which led to a broad police investigation five years ago. Both the clinic and several craft businesses were searched and the evidence is accordingly affected. The trial lasts a total of 22 days and the verdict is expected to be delivered in January 2026. The defendant faces several years in prison.

Support for the clinic

In the midst of this turbulence, the city of Wilhelmshaven has decided to support the clinic financially with grants. The Frisian district council also voted for closer cooperation with the clinics, which shows that despite the current difficulties there are efforts to strengthen and further develop the hospital.

Healthcare fraud in general

The Wilhelmshaven case falls into a worrying overall development in the healthcare system. According to a report from statutory health insurance companies, fraud is continuously increasing. The focus is particularly on medications such as the weight loss injection Ozempic and painkillers such as tilidine and fentanyl. In 2022 and 2023, fraud worth over 200 million euros was discovered. This is the highest amount since records began in 2008. Criminals are increasingly forging prescriptions for expensive medications, and health insurance companies are demanding compensation from pharmacies if counterfeit prescriptions are not recognized in time.

The statutory health insurance company (GKV) has found that around 50,000 reports of fraud in the healthcare sector have been received, an increase of over 20% compared to previous years. Crimes involving services that have been billed for but not provided are particularly common in the care sector. The GKV assumes that the number of unreported cases is high, which means that many cases of fraud are not discovered. A change to the Social Security Code is being called for to enable central billing capture, while proposals to use artificial intelligence to more quickly expose criminal activity are being discussed.

Overall, suspected healthcare fraud remains a pressing problem that raises not only financial but also ethical questions. The coming trial days in Oldenburg could not only decide the fate of the defendant, but also shed crucial light on the disgusting machinations in the health sector.

To find out more about the background and financial implications of this problem, you can read the reports from NDR here and from Tagesschau Read here.